AsianScientist (Jan. 16, 2012) – BIOTRONIK, manufacturer of cardiovascular medical devices, announced on Friday the opening of a new regional headquarters location based in Singapore – a move that emphasizes the strategic commitment of the company to build a powerful leadership position in the Asia Pacific region.
“BIOTRONIK will fully leverage the accelerated development of the Asia Pacific countries to further propel the industry-leading growth trajectory that the company has maintained during previous years despite the global economic downturn,” said Dr. Werner Braun, Global Managing Director, BIOTRONIK.
“The economic independence of BIOTRONIK has allowed us to deliver a uniquely sustainable value proposition to our customers – one that includes investment in activities, such as our landmark clinical research program and best-in-class clinical education – in an environment where we have seen our competitors de-investing,” he said.
BIOTRONIK’s further plans for full-scale business development in Asia Pacific will be coordinated by a team based out of the new headquarters in Asia, Braun added.
——
Source: BIOTRONIK.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
